Effect of endothelin-1 in man - Impact on basal and stimulated concentrations of luteinizing hormone, follicle-stimulating hormone, thyrotropin, growth hormone, corticotropin, and prolactin with and without pretreatment with nifedipine

Metabolism: Clinical and Experimental

Volumn 45, Issue 5, 1996, Pages 658-661

  Vierhapper, H ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; ENDOTHELIN 1; FOLLITROPIN; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; LUTEINIZING HORMONE; NIFEDIPINE; PROLACTIN; THYROTROPIN;

ADENOHYPOPHYSIS; ADULT; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN EXPERIMENT; HYPOPHYSIS FUNCTION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0029865311     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(96)90039-6     Document Type: Article

References (24)

1. A receptors mediate the signaling and secretory actions of endothelins in pituitary gonadotrophs. Endocrinology 130:465-474, 1992
2. Vierhapper H, Hollenstein U, Roden M, et al: Effect of endothelin-1 in man - Impact on basal and stimulated concentrations of luteinizing hormone, follicle-stimulating hormone, thyrotropin, growth hormone, corticotropin, and prolactin. Metabolism 42:902-906, 1993
3. Kiowski W, Lüscher TF, Linder L, et al: Endothelin-1 induced vasoconstriction in man: Reversal by calcium channel blockade but not by nitrovasodilators or endothelium-derived relaxing factor. Circulation 83:469-475, 1991
4. Gross PM, Wainman DS, Espinosa FJ: Differentiated metabolic stimulation of rat pituitary lobes by peripheral and central endothelin-1. Endocrinology 129:1110-1112, 1991
5. Waldhäusl W, Rath F: Development of antibodies to human growth hormone (hGH) in children of short stature with hGH. Acta Endocrinol (Copenh) 68:345-354, 1971
6. SAS: SAS User's Guide: Statistics. Cary, NC, SAS Institute, 1982
7. Stojilkovic SS, Iida T, Merelli F, et al: Calcium signaling and secretory responses in endothelin-stimulated anterior pituitary cells. Mol Pharmacol 39:762-770, 1991
8. Stojilkovic SS, Merelli F, Iida T, et al: Endothelin stimulation of cytosolic calcium and gonadotropin secretion in anterior pituitary cells. Science 248:1663-1666, 1990
9. Samson WK, Skala KD, Alexander BD, et al: Pituitary site of action of endothelin: Selective inhibition of prolactin release in vitro. Biochem Biophys Res Commun 169:737-743, 1990
10. Kanyicska B, Livingstone JD, Freeman ME: Long term exposure to dopamine reverses the inhibitory effect of endothelin-1 on prolactin secretion. Endocrinology 136:990-994, 1995
11. Calogero AE, Raiti F, Nicolosi G, et al: Effects of endothelin-1 and endothelin-3 on rat hypothalamic corticotrophinreleasing hormone and pituitary ACTH release in vitro. J Endocrinol 140:419-424, 1994
12. Takahashi K, Ghatei MA, Jones PM, et al: Endothelin in human brain and pituitary gland: Presence of immunoreactive endothelin, endothelin messenger ribonucleic acid, and endothelin receptors. J Clin Endocrinol Metab 72:693-699, 1991
13. Vierhapper H, Wagner O, Nowotny P, et al: Effect of endothelin-1 in man. Circulation 81:1415-1418, 1990
14. Vierhapper H, Nowotny P, Waldhäusl W: Effect of endothelin-1 in man: Impact on basal and adrenocorticotropin-stimulated concentrations of aldosterone. J Clin Endocrinol Metab 80:948-951, 1995
15. Vierhapper H: Endocrine effects of endothelin-1. Endothelium 3:113-120, 1995
16. Roden M, Vierhapper H, Liener K, et al: Endothelin-1-stimulated glucose production in vitro in the isolated perfused rat liver. Metabolism 41:290-295, 1992
17. Roden M, Prskavec M, Fürnsinn C, et al: Evidence for phosphoramidon-sensitive cleavage of big endothelin-1 involved in endothelin-stimulated hepatic glucose production. Regul Pept 51:207-213, 1994
18. Yanagisawa M, Kurihara H, Kimura S, et al: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411-415, 1988
19. Takahara J, Yunoki S, Yamane Y, et al: Effects of nifedipine on prolactin, growth hormone, and luteinizing hormone release by rat anterior pituitary in vitro. Proc Soc Exp Biol Med 162:31-33, 1979
20. Brabant G, Prank H, Hoang-Vu C, et al: Hypothylamic regulation of pulsatile thyrotropin secretion. J Clin Endocrinol Metab 72:145-150, 1991
21. Barbarino A, de Marinis L: Calcium antagonists and hormone release. II. Effects of verapamil on basal, gonadotropin-releasing hormone and thyrotropin-releasing hormone induced pituitary hormone release in normal subjects. J Clin Endocrinol Metab 51:749-753, 1980
22. Struthers AD, Millar JA, Beastal GH, et al: Calcium antagonists and hormone release: Effect of nifedipine on luteinizing hormone-releasing hormone and thyrotropin-releasing hormone-induced pituitary hormone release. J Clin Endocrinol Metab 56:401-404, 1983
23. Jackson RV, Jackson AJ, Grice JE, et al: Nifedipine blocks ACTH and cortisol release in man. Clin Exp Pharmacol Physiol 16:257-261, 1989
24. Vierhapper H, Wagner OF, Nowotny P, et al: Effect of endothelin-1 in man: Pretreatment with nifedipine, with indomethacin and with cyclosporine A. Eur J Clin Invest 22:55-59, 1992